Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.3, 2014-01, pp. : 1343-1349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Oxymatrine inhibits non–small cell lung cancer via suppression of EGFR signaling pathway

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 208-218

John Wiley & Sons Inc

Access to resources Recommend Favorite

(−)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway

By Chen Yue Wang Xiao-Qian Zhang Qi Zhu Jian-Yun Li Yuan Xie Chun-Feng Li Xiao-Ting Wu Jie-Shu Geng Shan-Shan Zhong Cai-Yun Han Hong-Yu

Nutrients, Vol. 9, Iss. 6, 2017-06 ,pp. : 572-572

MDPI

Access to resources Recommend Favorite

Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer

By Miyamoto Yuji Suyama Koichi Baba Hideo

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 752-752

MDPI

Access to resources Recommend Favorite

Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 650-654

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components

THE PROSTATE, Vol. 78, Iss. 5, 2018-04 ,pp. : 343-352

John Wiley & Sons Inc

Access to resources Recommend Favorite